Cargando…
Interactomic and Pharmacological Insights on Human Sirt-1
Sirt-1 is defined as a nuclear protein involved in the molecular mechanisms of inflammation and neurodegeneration through the de-acetylation of many different substrates even if experimental data in mouse suggest both its cytoplasmatic presence and nucleo-cytoplasmic shuttling upon oxidative stress....
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311038/ https://www.ncbi.nlm.nih.gov/pubmed/22470339 http://dx.doi.org/10.3389/fphar.2012.00040 |
_version_ | 1782227735432658944 |
---|---|
author | Sharma, Ankush Gautam, Vasu Costantini, Susan Paladino, Antonella Colonna, Giovanni |
author_facet | Sharma, Ankush Gautam, Vasu Costantini, Susan Paladino, Antonella Colonna, Giovanni |
author_sort | Sharma, Ankush |
collection | PubMed |
description | Sirt-1 is defined as a nuclear protein involved in the molecular mechanisms of inflammation and neurodegeneration through the de-acetylation of many different substrates even if experimental data in mouse suggest both its cytoplasmatic presence and nucleo-cytoplasmic shuttling upon oxidative stress. Since the experimental structure of human Sirt-1 has not yet been reported, we have modeled its 3D structure, highlighted that it is composed by four different structural regions: N-terminal region, allosteric site, catalytic core and C-terminal region, and underlined that the two terminal regions have high intrinsic disorder propensity and numerous putative phosphorylation sites. Many different papers report experimental studies related to its functional activators because Sirt-1 is implicated in various diseases and cancers. The aim of this article is (i) to present interactomic studies based human Sirt-1 to understand its most important functional relationships in the light of the gene–protein interactions that control major metabolic pathways and (ii) to show by docking studies how this protein binds some activator molecules in order to evidence structural determinants, physico-chemical features and those residues involved in the formation of complexes. |
format | Online Article Text |
id | pubmed-3311038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Frontiers Research Foundation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33110382012-04-02 Interactomic and Pharmacological Insights on Human Sirt-1 Sharma, Ankush Gautam, Vasu Costantini, Susan Paladino, Antonella Colonna, Giovanni Front Pharmacol Pharmacology Sirt-1 is defined as a nuclear protein involved in the molecular mechanisms of inflammation and neurodegeneration through the de-acetylation of many different substrates even if experimental data in mouse suggest both its cytoplasmatic presence and nucleo-cytoplasmic shuttling upon oxidative stress. Since the experimental structure of human Sirt-1 has not yet been reported, we have modeled its 3D structure, highlighted that it is composed by four different structural regions: N-terminal region, allosteric site, catalytic core and C-terminal region, and underlined that the two terminal regions have high intrinsic disorder propensity and numerous putative phosphorylation sites. Many different papers report experimental studies related to its functional activators because Sirt-1 is implicated in various diseases and cancers. The aim of this article is (i) to present interactomic studies based human Sirt-1 to understand its most important functional relationships in the light of the gene–protein interactions that control major metabolic pathways and (ii) to show by docking studies how this protein binds some activator molecules in order to evidence structural determinants, physico-chemical features and those residues involved in the formation of complexes. Frontiers Research Foundation 2012-03-23 /pmc/articles/PMC3311038/ /pubmed/22470339 http://dx.doi.org/10.3389/fphar.2012.00040 Text en Copyright © 2012 Sharma, Gautam, Costantini, Paladino and Colonna. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited. |
spellingShingle | Pharmacology Sharma, Ankush Gautam, Vasu Costantini, Susan Paladino, Antonella Colonna, Giovanni Interactomic and Pharmacological Insights on Human Sirt-1 |
title | Interactomic and Pharmacological Insights on Human Sirt-1 |
title_full | Interactomic and Pharmacological Insights on Human Sirt-1 |
title_fullStr | Interactomic and Pharmacological Insights on Human Sirt-1 |
title_full_unstemmed | Interactomic and Pharmacological Insights on Human Sirt-1 |
title_short | Interactomic and Pharmacological Insights on Human Sirt-1 |
title_sort | interactomic and pharmacological insights on human sirt-1 |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311038/ https://www.ncbi.nlm.nih.gov/pubmed/22470339 http://dx.doi.org/10.3389/fphar.2012.00040 |
work_keys_str_mv | AT sharmaankush interactomicandpharmacologicalinsightsonhumansirt1 AT gautamvasu interactomicandpharmacologicalinsightsonhumansirt1 AT costantinisusan interactomicandpharmacologicalinsightsonhumansirt1 AT paladinoantonella interactomicandpharmacologicalinsightsonhumansirt1 AT colonnagiovanni interactomicandpharmacologicalinsightsonhumansirt1 |